Due to the very high intrahepatic and blood lipid levels in patients with NAFLD, the formation and accumulation of fat in the liver can increase both VLDL- Apolipoprotein B (ApoB) and VLDL-TG production rates (PRs) [32] (Fig. 3). Here, APOB is linked to metabolic dysfunction-associated steatotic liver disease.